Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer

Su, 2017, Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122, Mol. Cancer, 16, 171, 10.1186/s12943-017-0737-1 Zhu, 2018, miR-145 antagonizes SNAI1-mediated stemness and radiation resistance in colorectal cancer, Mol. Ther., 26, 744, 10.1016/j.ymthe.2017.12.023 Bai, 2018, Cancer stem cell in breast cancer therapeutic resistance, Cancer Treat. Rev., 69, 152, 10.1016/j.ctrv.2018.07.004 Laissue, 2019, The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis, Mol. Cancer, 18, 5, 10.1186/s12943-019-0938-x Liu, 2019, Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma, J. Exp. Clin. Cancer Res., 38, 447, 10.1186/s13046-019-1412-8 Ma, 2018, Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis, Mol. Cancer, 17, 139, 10.1186/s12943-018-0890-1 Ghosh, 2019, The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports, Signal Transduct. Target. Ther., 4, 42, 10.1038/s41392-019-0075-4 Cristóbal, 2018, Potential therapeutic impact of miR-145 deregulation in colorectal cancer, Mol. Ther., 26, 1399, 10.1016/j.ymthe.2018.05.008 Huang, 2020, RNAi-mediated control of CRISPR functions, Theranostics, 10, 6661, 10.7150/thno.44880 Lin, 2018, Chemotherapy-induced long non-coding RNA 1 promotes metastasis and chemo-resistance of TSCC via the Wnt/β-catenin signaling pathway, Mol. Ther., 26, 1494, 10.1016/j.ymthe.2018.04.002 Herrera, 2018, Differential distribution and enrichment of non-coding RNAs in exosomes from normal and cancer-associated fibroblasts in colorectal cancer, Mol. Cancer, 17, 114, 10.1186/s12943-018-0863-4 Warner, 2019, A novel chimeric poxvirus encoding hNIS is tumor-tropic, imageable, and synergistic with radioiodine to sustain colon cancer regression, Mol. Ther. Oncolytics, 13, 82, 10.1016/j.omto.2019.04.001 Yue, 2018, A positive feed-forward loop between lncRNA-CYTOR and Wnt/β-catenin signaling promotes metastasis of colon cancer, Mol. Ther., 26, 1287, 10.1016/j.ymthe.2018.02.024 Liu, 2018, lncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3, Mol. Cancer, 17, 118, 10.1186/s12943-018-0873-2 Yu, 2018, lncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway, J. Exp. Clin. Cancer Res., 37, 222, 10.1186/s13046-018-0896-y Yang, 2019, Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling, Mol. Cancer, 18, 31, 10.1186/s12943-019-0955-9 Zhu, 2017, lncRNA ODRUL contributes to osteosarcoma progression through the miR-3182/MMP2 axis, Mol. Ther., 25, 2383, 10.1016/j.ymthe.2017.06.027 Shao, 2018, lncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation, Mol. Cancer, 17, 173, 10.1186/s12943-018-0921-y Rimassa, 2019, Management of adverse events associated with tyrosine kinase inhibitors: improving outcomes for patients with hepatocellular carcinoma, Cancer Treat. Rev., 77, 20, 10.1016/j.ctrv.2019.05.004 Cruz, 2020, Mutant allele-specific CRISPR disruption in DYT1 dystonia fibroblasts restores cell function, Mol. Ther. Nucleic Acids, 21, 1, 10.1016/j.omtn.2020.05.009 Elsedawy, 2020, Oncolytic activity of targeted picornaviruses formulated as synthetic infectious RNA, Mol. Ther. Oncolytics, 17, 484, 10.1016/j.omto.2020.05.003 Zhou, 2019, DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy, Signal Transduct. Target. Ther., 4, 56, 10.1038/s41392-019-0094-1 Tsai, 2018, Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer, Mol. Cancer, 17, 72, 10.1186/s12943-018-0821-1 Gupta, 2020, Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases, Biochim. Biophys. Acta Rev. Cancer, 1873, 188316, 10.1016/j.bbcan.2019.188316 Wang, 2018, The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68, Mol. Cancer, 17, 110, 10.1186/s12943-018-0860-7 Wu, 2018, Targeting Gas6/TAM in cancer cells and tumor microenvironment, Mol. Cancer, 17, 20, 10.1186/s12943-018-0769-1 Andrzejewska, 2020, Mesenchymal stem cells injected into carotid artery to target focal brain injury home to perivascular space, Theranostics, 10, 6615, 10.7150/thno.43169 Ma, 2018, lncRNA GCAWKR promotes gastric cancer development by scaffolding the chromatin modification factors WDR5 and KAT2A, Mol. Ther., 26, 2658, 10.1016/j.ymthe.2018.09.002 Wei, 2019, The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma, Mol. Cancer, 18, 147, 10.1186/s12943-019-1086-z Xie, 2019, Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer, Signal Transduct. Target. Ther., 4, 51, 10.1038/s41392-019-0086-1 Zhao, 2018, The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1, Mol. Cancer, 17, 69, 10.1186/s12943-018-0820-2 Liu, 2019, Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer, Signal Transduct. Target. Ther., 4, 49, 10.1038/s41392-019-0085-2 Ding, 2018, The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1, Mol. Cancer, 17, 63, 10.1186/s12943-018-0813-1 Zhang, 2020, FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism, Theranostics, 10, 6561, 10.7150/thno.44868 Kawamura, 2020, Validation of gene therapy for mutant mitochondria by delivering mitochondrial RNA using a MITO-Porter, Mol. Ther. Nucleic Acids, 20, 687, 10.1016/j.omtn.2020.04.004 Le Grand, 2020, Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation, Theranostics, 10, 6411, 10.7150/thno.42602 Wang, 2019, ncRNA-encoded peptides or proteins and cancer, Mol. Ther., 27, 1718, 10.1016/j.ymthe.2019.09.001 Hewes, 2020, gRNA sequence heterology tolerance catalyzed by CRISPR/Cas in an in vitro homology-directed repair reaction, Mol. Ther. Nucleic Acids, 20, 568, 10.1016/j.omtn.2020.03.012 Li, 2019, Clonal replacement of novel T cells: a new phenomenon in the tumor microenvironment following PD-1 blockade, Signal Transduct. Target. Ther., 4, 43, 10.1038/s41392-019-0077-2 Zhang, 2019, Long non-coding RNAs in oral squamous cell carcinoma: biologic function, mechanisms and clinical implications, Mol. Cancer, 18, 102, 10.1186/s12943-019-1021-3 Li, 2018, Targeting long noncoding RNA in glioma: a pathway perspective, Mol. Ther. Nucleic Acids, 13, 431, 10.1016/j.omtn.2018.09.023 Horita, 2019, lncRNA UCA1-mediated Cdc42 signaling promotes oncolytic vaccinia virus cell-to-cell spread in ovarian cancer, Mol. Ther. Oncolytics, 13, 35, 10.1016/j.omto.2019.03.003 Fan, 2019, A cohesin-mediated intrachromosomal loop drives oncogenic ROR lncRNA to accelerate tumorigenesis, Mol. Ther., 27, 2182, 10.1016/j.ymthe.2019.07.020 Peng, 2018, New insights into long noncoding RNAs and their roles in glioma, Mol. Cancer, 17, 61, 10.1186/s12943-018-0812-2 Xie, 2018, Upregulation of lncRNA ADAMTS9-AS2 promotes salivary adenoid cystic carcinoma metastasis via PI3K/Akt and MEK/Erk signaling, Mol. Ther., 26, 2766, 10.1016/j.ymthe.2018.08.018 Zhao, 2018, lncRNA PFAR promotes lung fibroblast activation and fibrosis by targeting miR-138 to regulate the YAP1-twist axis, Mol. Ther., 26, 2206, 10.1016/j.ymthe.2018.06.020 Xu, 2019, lncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2, Mol. Cancer, 18, 135, 10.1186/s12943-019-1063-6 Wang, 2019, Targeted therapeutic options and future perspectives for HER2-positive breast cancer, Signal Transduct. Target. Ther., 4, 34, 10.1038/s41392-019-0069-2 Li, 2020, Recurrence-associated long non-coding RNA LNAPPCC facilitates colon cancer progression via forming a positive feedback loop with PCDH7, Mol. Ther. Nucleic Acids, 20, 545, 10.1016/j.omtn.2020.03.017 Wang, 2020, Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer, Cancer Lett., 488, 40, 10.1016/j.canlet.2020.05.027 Gan, 2020, Modulation of apoptosis by plant polysaccharides for exerting anti-cancer effects: a review, Front. Pharmacol., 11, 792, 10.3389/fphar.2020.00792 Ferrer, 2020, Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy, Cancer Lett., 488, 9, 10.1016/j.canlet.2020.05.026 Zhang, 2019, The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma, Mol. Cancer, 18, 120, 10.1186/s12943-019-1044-9 Wang, 2019, The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs, Mol. Cancer, 18, 115, 10.1186/s12943-019-1032-0 Li, 2019, A compound AC1Q3QWB selectively disrupts HOTAIR-mediated recruitment of PRC2 and enhances cancer therapy of DZNep, Theranostics, 9, 4608, 10.7150/thno.35188 Singh, 2019, Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles, Signal Transduct. Target. Ther., 4, 33, 10.1038/s41392-019-0068-3 Gu, 2019, A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer, Mol. Cancer, 18, 109, 10.1186/s12943-019-1037-8 Zhang, 2019, ZBTB7A, a miR-663a target gene, protects osteosarcoma from endoplasmic reticulum stress-induced apoptosis by suppressing lncRNA GAS5 expression, Cancer Lett., 448, 105, 10.1016/j.canlet.2019.01.046 Huang, 2018, lncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis, Cancer Lett., 437, 56, 10.1016/j.canlet.2018.08.024 Tellez-Gabriel, 2019, Circulating tumor cells as a tool for assessing tumor heterogeneity, Theranostics, 9, 4580, 10.7150/thno.34337 Wang, 2019, A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis, Mol. Cancer, 18, 28, 10.1186/s12943-019-0957-7 Hu, 2020, Single-cell transcriptome analysis reveals intratumoral heterogeneity in ccRCC, which results in different clinical outcomes, Mol. Ther., 28, 1658, 10.1016/j.ymthe.2020.04.023 Cui, 2020, circ_001653 silencing promotes the proliferation and ECM synthesis of NPCs in IDD by downregulating miR-486-3p-mediated CEMIP, Mol. Ther. Nucleic Acids, 20, 385, 10.1016/j.omtn.2020.01.026 Wang, 2018, lncRNA MIR31HG targets HIF1A and p21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression, Mol. Cancer, 17, 162, 10.1186/s12943-018-0916-8 Pulakat, 2020, Pro-senescence and anti-senescence mechanisms of cardiovascular aging: cardiac microRNA regulation of longevity drug-induced autophagy, Front. Pharmacol., 11, 774, 10.3389/fphar.2020.00774 Xu, 2019, Hypoxia induces drug resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6 feedback loop, Mol. Ther., 27, 1810, 10.1016/j.ymthe.2019.05.017 Hu, 2019, Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment, Signal Transduct. Target. Ther., 4, 28, 10.1038/s41392-019-0062-9 Wang, 2019, Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway, Mol. Cancer, 18, 84, 10.1186/s12943-019-1013-3 Song, 2019, lncITPF promotes pulmonary fibrosis by targeting hnRNP-L depending on its host gene ITGBL1, Mol. Ther., 27, 380, 10.1016/j.ymthe.2018.08.026 Zhai, 2019, A positive feed-forward loop between lncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma, Mol. Cancer, 18, 81, 10.1186/s12943-019-0998-y Wei, 2019, Silencing of lncRNA MALAT1 prevents inflammatory injury after lung transplant ischemia-reperfusion by downregulation of IL-8 via p300, Mol. Ther. Nucleic Acids, 18, 285, 10.1016/j.omtn.2019.05.009 Liu, 2019, lncRNA MALAT1 accelerates wound healing of diabetic mice transfused with modified autologous blood via the HIF-1α signaling pathway, Mol. Ther. Nucleic Acids, 17, 504, 10.1016/j.omtn.2019.05.020 Viennois, 2019, Host-derived fecal microRNAs can indicate gut microbiota healthiness and ability to induce inflammation, Theranostics, 9, 4542, 10.7150/thno.35282 Jin, 2019, p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma, Mol. Cancer, 18, 38, 10.1186/s12943-019-0993-3 Shen, 2020, SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy, Theranostics, 10, 4466, 10.7150/thno.42478 Hu, 2019, lncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis, Mol. Cancer, 18, 167, 10.1186/s12943-019-1097-9 Yang, 2019, circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation, Mol. Cancer, 18, 158, 10.1186/s12943-019-1094-z Huang, 2018, lncRNA PVT1 triggers cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 axis, Mol. Cancer, 17, 98, 10.1186/s12943-018-0845-6 Zhang, 2018, lncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer, Mol. Cancer, 17, 87, 10.1186/s12943-018-0829-6 Jiang, 2019, lncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus, J. Exp. Clin. Cancer Res., 38, 365, 10.1186/s13046-019-1364-z Mai, 2019, Molecular pattern of lncRNAs in hepatocellular carcinoma, J. Exp. Clin. Cancer Res., 38, 198, 10.1186/s13046-019-1213-0 Buckley, 2020, Generation and profiling of tumor-homing induced neural stem cells from the skin of cancer patients, Mol. Ther., 28, 1614, 10.1016/j.ymthe.2020.04.022 Chen, 2018, STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy, Mol. Cancer, 17, 6, 10.1186/s12943-017-0756-y Schenkwein, 2020, Efficient nuclease-directed integration of lentivirus vectors into the human ribosomal DNA locus, Mol. Ther., 10.1016/j.ymthe.2020.05.019 Xue, 2020, PACAP neuropeptide promotes hepatocellular protection via CREB-KLF4 dependent autophagy in mouse liver ischemia reperfusion injury, Theranostics, 10, 4453, 10.7150/thno.42354 Stojic, 2016, Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functions, Nat. Commun., 7, 10406, 10.1038/ncomms10406 Shi, 2020, The potential therapeutic role of exosomal microRNA-520b derived from normal fibroblasts in pancreatic cancer, Mol. Ther. Nucleic Acids, 20, 373, 10.1016/j.omtn.2019.12.029 Wu, 2018, Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours, Nat. Commun., 9, 4624, 10.1038/s41467-018-06853-3 Li, 2019, Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme, J. Exp. Clin. Cancer Res., 38, 380, 10.1186/s13046-019-1371-0 Zhao, 2019, P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs, J. Exp. Clin. Cancer Res., 38, 379, 10.1186/s13046-019-1375-9 Ma, 2018, Membrane-lipid associated lncRNA: a new regulator in cancer signaling, Cancer Lett., 419, 27, 10.1016/j.canlet.2018.01.008 Huang, 2018, lncRNAs and circRNAs from the same gene: masterpieces of RNA splicing, Cancer Lett., 415, 49, 10.1016/j.canlet.2017.11.034 Fu, 2017, lncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9, Cancer Lett., 410, 68, 10.1016/j.canlet.2017.09.019 Shi, 2019, lncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway, J. Exp. Clin. Cancer Res., 38, 375, 10.1186/s13046-019-1363-0 Luo, 2019, lncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling, Nat. Commun., 10, 2571, 10.1038/s41467-019-09784-9 Yan, 2019, lncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer, J. Exp. Clin. Cancer Res., 38, 356, 10.1186/s13046-019-1356-z Liu, 2020, Nondestructive analysis of tumor-associated membrane protein MUC1 in living cells based on dual-terminal amplification of a DNA ternary complex, Theranostics, 10, 4410, 10.7150/thno.42951 Wu, 2019, Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells, J. Exp. Clin. Cancer Res., 38, 237, 10.1186/s13046-019-1239-3 Liu, 2018, lncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling, J. Exp. Clin. Cancer Res., 37, 279, 10.1186/s13046-018-0950-9 Li, 2018, Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme, J. Exp. Clin. Cancer Res., 37, 265, 10.1186/s13046-018-0941-x Rossi, 2019, lncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β, Nat. Commun., 10, 1969, 10.1038/s41467-019-09754-1 Dong, 2018, SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88, J. Exp. Clin. Cancer Res., 37, 202, 10.1186/s13046-018-0875-3 Casciello, 2020, G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome, Theranostics, 10, 4515, 10.7150/thno.41453 Wu, 2020, Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis, Theranostics, 10, 4544, 10.7150/thno.40532 Xin, 2020, miR-155 accelerates the growth of human liver cancer cells by activating CDK2 via targeting H3F3A, Mol. Ther. Oncolytics, 17, 471, 10.1016/j.omto.2020.05.002 Xu, 2018, SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma, J. Exp. Clin. Cancer Res., 37, 81, 10.1186/s13046-018-0747-x Chang, 2018, lncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1, J. Exp. Clin. Cancer Res., 37, 56, 10.1186/s13046-018-0724-4 Huang, 2017, lncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway, J. Exp. Clin. Cancer Res., 36, 194, 10.1186/s13046-017-0666-2 Feng, 2019, lncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer, Cancer Lett., 465, 105, 10.1016/j.canlet.2019.09.002 Song, 2019, Genome-wide identification of DNA-PKcs-associated RNAs by RIP-Seq, Signal Transduct. Target. Ther., 4, 22, 10.1038/s41392-019-0057-6 Huang, 2019, Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response, Cancer Lett., 459, 86, 10.1016/j.canlet.2019.05.038 Huo, 2017, Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells, Mol. Cancer, 16, 165, 10.1186/s12943-017-0734-4 Gu, 2018, Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer, Cancer Lett., 434, 1, 10.1016/j.canlet.2018.06.039 Fan, 2017, Role of long non-coding RNAs in glucose metabolism in cancer, Mol. Cancer, 16, 130, 10.1186/s12943-017-0699-3 Lu, 2018, The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling, Cancer Lett., 432, 156, 10.1016/j.canlet.2018.06.013 Fan, 2018, lncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells, Cancer Lett., 429, 89, 10.1016/j.canlet.2018.05.010 Luo, 2018, Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms, Mol. Cancer, 17, 14, 10.1186/s12943-018-0763-7 Li, 2020, circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma, Theranostics, 10, 4395, 10.7150/thno.43239 Hosseini, 2017, Dysregulated expression of long noncoding RNAs in gynecologic cancers, Mol. Cancer, 16, 107, 10.1186/s12943-017-0671-2 Alame, 2020, The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities, Theranostics, 10, 4383, 10.7150/thno.42986 Ye, 2020, Signal amplification and quantification on lateral flow assays by laser excitation of plasmonic nanomaterials, Theranostics, 10, 4359, 10.7150/thno.44298 Chang, 2018, HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer, Cancer Lett., 433, 43, 10.1016/j.canlet.2018.06.029 Sohretoglu, 2019, ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells, Signal Transduct. Target. Ther., 4, 21, 10.1038/s41392-019-0056-7 Kanwal, 2017, MicroRNAs in prostate cancer: functional role as biomarkers, Cancer Lett., 407, 9, 10.1016/j.canlet.2017.08.011 Tichon, 2016, A conserved abundant cytoplasmic long noncoding RNA modulates repression by Pumilio proteins in human cells, Nat. Commun., 7, 12209, 10.1038/ncomms12209 Jiang, 2017, lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition, Cancer Lett., 405, 46, 10.1016/j.canlet.2017.06.009 Shih, 2017, Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression, Nat. Commun., 8, 15874, 10.1038/ncomms15874 Nepstad, 2019, Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells, Signal Transduct. Target. Ther., 4, 20, 10.1038/s41392-019-0050-0 Selvaraj, 2019, Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy, Mol. Ther., 27, 2147, 10.1016/j.ymthe.2019.08.011 Kim, 2020, Characterization of cationic bolaamphiphile vesicles for siRNA delivery into tumors and brain, Mol. Ther. Nucleic Acids, 20, 359, 10.1016/j.omtn.2020.02.011 Xu, 2020, Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy, Theranostics, 10, 4349, 10.7150/thno.43402 Liu, 2020, The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials, Cancer Lett., 487, 45, 10.1016/j.canlet.2020.05.019 Shen, 2020, miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss, Theranostics, 10, 4334, 10.7150/thno.42982 von Knethen, 2019, PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology, Signal Transduct. Target. Ther., 4, 18, 10.1038/s41392-019-0053-x